Zacks Small Cap Analysis – SNGX: Settlement with EMA on Second Confirmatory Trial for HyBryte… – Model Slux
By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Enterprise Replace Reaches Settlement with European Medicines Company on Second Confirmatory Trial for HyBryte On April 3, 2024, Soligenix, Inc. (NASDAQ:SNGX) introduced it has reached settlement with the European Medicines Company (EMA) on the important thing design parts for a confirmatory Part 3 trial … Read more
